Indaptus Therapeutics

(NASDAQ) INDP

Current Price$1.13

Market Cap$138.16M

Since IPO (2021)-100%

5 Year-100%

1 Year-89%

1 Month-65%

Indaptus Therapeutics Financials at a Glance

Market Cap

$138.16M

Revenue (TTM)

$0.00

Net Income (TTM)

-$18.86M

EPS (TTM)

-$16.05

P/E Ratio

-0.08

Dividend

$0.00

Beta (Volatility)

1.22 (Average)

Dividend

$0.00

Beta (Volatility)

1.22 (Average)

Price

$1.13

Volume

248

Open

$1.14

Price

$1.13

Volume

248

Open

$1.14

Previous Close

$1.22

Daily Range

$1.12 - $1.15

52-Week Range

$0.92 - $19.91

Dividend

$0.00

Beta (Volatility)

1.22 (Average)

Price

$1.13

Volume

248

Open

$1.14

Previous Close

$1.22

Daily Range

$1.12 - $1.15

52-Week Range

$0.92 - $19.91

INDP News

Indaptus Posts Narrower Loss in Q2

Motley Fool Markets TeamAug 13, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Indaptus Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

David Elliot Lazar; Jeffrey A. Meckler

Website

indaptusrx.com

Headquarters

New York City, NY 10019, US

INDP Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-932%

Return on Capital

-14%

Return on Assets

-9%

Earnings Yield

-12.50%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$138.16M

Shares Outstanding

113.24M

Volume

248

Avg. Volume

67.82K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$19.83M

EBITDA

-$19.83M

Operating Cash Flow

-$14.82M

Capital Expenditure

-$4.00

Free Cash Flow

-$14.82M

Cash & ST Invst.

$8.51M

Total Debt

$0.00

Indaptus Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$138.16M

N/A

Market Cap/Employee

$19.74M

N/A

Employees

N/A

Net Income

-$2.54M

+43.9%

EBITDA

-$2.16M

+52.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$1.50M

-60.9%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-8.65%

N/A

Return on Invested Capital

-13.96%

N/A

Free Cash Flow

-$7.01M

-38.9%

Operating Cash Flow

-$7.01M

-38.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NKGNNKGen Biotech, Inc. Common Stock

NKGNNKGen Biotech, Inc. Common Stock$0.06+0.00%

SLRXSalarius Pharmaceuticals, Inc.

SLRXSalarius Pharmaceuticals, Inc.$0.84+29.23%

GTBPGT Biopharma, Inc.

GTBPGT Biopharma, Inc.$0.39-10.41%

REVBRevelation Biosciences, Inc.

REVBRevelation Biosciences, Inc.$1.07-0.47%

PTIXProtagenic Therapeutics, Inc.

PTIXProtagenic Therapeutics, Inc.$0.47-28.39%

ATXIAvenue Therapeutics, Inc.

ATXIAvenue Therapeutics, Inc.$0.23+4.50%

LIPOLipella Pharmaceuticals Inc.

LIPOLipella Pharmaceuticals Inc.$0.11-25.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$42.97+0.00%

ONDSOndas

ONDSOndas$9.71+0.07%

TET1 Energy Inc.

TET1 Energy Inc.$10.42+0.29%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$82.05+0.05%

CODXCo-Diagnostics

CODXCo-Diagnostics$9.64+0.90%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$39.26-0.05%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.15+0.07%

Questions About INDP

What is the current price of Indaptus Therapeutics?

Indaptus Therapeutics is trading at $1.13 per share.

What is the 52-week range for Indaptus Therapeutics?

Over the past 52 weeks, Indaptus Therapeutics has traded between $0.92 and $19.91.

How much debt does Indaptus Therapeutics have?

As of the most recent reporting period, Indaptus Therapeutics reported total debt of $0.00.

How much cash does Indaptus Therapeutics have on hand?

Indaptus Therapeutics reported $1.50M in cash and cash equivalents in its most recent financial results.

What is Indaptus Therapeutics’s dividend yield?

Indaptus Therapeutics does not currently have a dividend yield.

Indaptus Therapeutics

Indaptus Therapeutics Financials at a Glance

INDP News

Indaptus Posts Narrower Loss in Q2

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Indaptus Therapeutics

INDP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Indaptus Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About INDP

What is the current price of Indaptus Therapeutics?

What is the 52-week range for Indaptus Therapeutics?

How much debt does Indaptus Therapeutics have?

How much cash does Indaptus Therapeutics have on hand?

What is Indaptus Therapeutics’s dividend yield?

Premium Investing Services